Literature DB >> 15622012

A longitudinal study of behavior in frontotemporal dementia and primary progressive aphasia.

Cecile A Marczinski1, Wilda Davidson, Andrew Kertesz.   

Abstract

OBJECTIVE: To evaluate the construct validity of the Frontal Behavioral Inventory (FBI) and to describe the evolution of the behavioral abnormalities of the behavioral and aphasic presentations of frontotemporal dementia (FTD) by means of a 3-year longitudinal study.
BACKGROUND: The FBI is a standardized behavioral questionnaire useful in the diagnosis and quantification of the personality and behavior disorder FTD.
METHOD: Patients who had three consecutive yearly assessments with the FBI were selected, 12 with the behavioral variant of FTD (FTD-bv) and 14 with Primary Progressive Aphasia (PPA).
RESULTS: FBI scores rose as the disease progressed in both the FTD-bv and PPA groups over the 3 years of testing. Initial mean FBI scores of the FTD-bv group were above the cutoff for FTD as established for this diagnosis with previous standardization. By the third year, the mean FBI score of PPA patients was also above the established cutoff for FTD.
CONCLUSIONS: The outcome of the study demonstrates that the FBI is sensitive to changes in behavior and personality in both variants of FTD. The FBI can be used to describe the evolution of symptoms and the course of the illness of Pick complex patients who present initially with FTD-bv or who present with PPA and subsequently develop the behavioral disorder.

Entities:  

Mesh:

Year:  2004        PMID: 15622012

Source DB:  PubMed          Journal:  Cogn Behav Neurol        ISSN: 1543-3633            Impact factor:   1.600


  30 in total

Review 1.  Clinical assessment of social cognitive function in neurological disorders.

Authors:  Julie D Henry; William von Hippel; Pascal Molenberghs; Teresa Lee; Perminder S Sachdev
Journal:  Nat Rev Neurol       Date:  2015-12-16       Impact factor: 42.937

2.  Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment.

Authors:  Mandana Modirrousta; Bruce H Price; Bradford C Dickerson
Journal:  Neurodegener Dis Manag       Date:  2013-04-01

3.  Neuropsychiatric symptom profile differs based on pathology in patients with clinically diagnosed behavioral variant frontotemporal dementia.

Authors:  Gabriel C Léger; Sarah J Banks
Journal:  Dement Geriatr Cogn Disord       Date:  2013-10-10       Impact factor: 2.959

Review 4.  The epidemiology of frontotemporal dementia.

Authors:  Chiadi U Onyike; Janine Diehl-Schmid
Journal:  Int Rev Psychiatry       Date:  2013-04

5.  Organizing a Series of Education and Support Conferences for Caregivers of Individuals With Frontotemporal Dementia and Primary Progressive Aphasia.

Authors:  Sarah Banks; Emily Rogalski; Jennifer Medina; Andrea Skoglund; Darby Morhardt
Journal:  Alzheimers Care Q       Date:  2006-10-01

6.  Longitudinal patterns of semantic and episodic memory in frontotemporal lobar degeneration and Alzheimer's disease.

Authors:  Sharon X Xie; David J Libon; Xingmei Wang; Lauren Massimo; Peachie Moore; Luisa Vesely; Alea Khan; Anjan Chatterjee; H Branch Coslett; Howard I Hurtig; Tsao-Wei Liang; Murray Grossman
Journal:  J Int Neuropsychol Soc       Date:  2009-12-11       Impact factor: 2.892

7.  Generalized and symptom-specific insight in behavioral variant frontotemporal dementia and primary progressive aphasia.

Authors:  Sarah Jane Banks; Sandra Weintraub
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

Review 8.  Diagnosis and management of behavioral issues in frontotemporal dementia.

Authors:  Masood Manoochehri; Edward D Huey
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 9.  Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes.

Authors:  Michał Harciarek; Stephanie Cosentino
Journal:  Int Rev Psychiatry       Date:  2013-04

10.  Phenomenology and anatomy of abnormal behaviours in primary progressive aphasia.

Authors:  Jonathan D Rohrer; Jason D Warren
Journal:  J Neurol Sci       Date:  2010-04-18       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.